Skip to content
- Association of a novel BRCA2 mutation with prostate cancer risk further supports germline genetic testing.
- Foley GR, Marthick JR, Ostrander EA, Stanford JL, Dickinson JL, FitzGerald L.
- Eur J Cancer. 2023 Feb 1;180:155-157. doi: 10.1016/j.ejca.2022.11.034. Epub ahead of print.
- Treatment Complexities Continue to Mount in Gynecologic Cancers.
- Lovely B.
- OncLive. OncologyLive. 2023 Jan 3;23(24):35.
- Artificial intelligence-based recognition for variant pathogenicity of BRCA1 using AlphaFold2-predicted structures.
- Li C, Zhang L, Zhuo Z, Su F, Li H, Xu S, Liu Y, Zhang Z, Xie Y, Yu X, Bian L, Xiao F.
- Theranostics. 2023 Jan 1;13(1):391-402. doi: 10.7150/thno.79362.